Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Total Non-Current Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹2.29 Cr₹3.59 Cr₹2.09 Cr₹4.07 Cr₹3.92 Cr

What is the latest Total Non-Current Liabilities ratio of INDO US BIOTECH ?

The latest Total Non-Current Liabilities ratio of INDO US BIOTECH is ₹2.29 Cr based on Mar2025 Standalone results.
Year Total Non-Current Liabilities
Mar2025₹2.29 Cr
Mar2024₹3.59 Cr
Mar2023₹2.09 Cr
Mar2022₹4.07 Cr
Mar2021₹3.92 Cr

How is Total Non-Current Liabilities of INDO US BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹2.29 Cr
-36.14
Mar2024 ₹3.59 Cr
71.41
Mar2023 ₹2.09 Cr
-48.61
Mar2022 ₹4.07 Cr
3.96
Mar2021 ₹3.92 Cr -

Compare Total Non-Current Liabilities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹253.7 Cr 1.9% -3.4% -47.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,989.8 Cr 1.1% -9.5% -24.8% Stock Analytics
KAVERI SEED COMPANY ₹5,250.4 Cr -4.6% -4% 21.7% Stock Analytics
VENKYS (INDIA) ₹1,873.3 Cr -1.7% -8.9% -20.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,167.3 Cr -4.3% -10.7% -22.8% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹489.1 Cr 3.1% -4.7% 30.5% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

1.9%

-3.4%

-47.6%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses